These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 16682838

  • 1. Treatment of post-partum thyrotoxicosis.
    Azizi F.
    J Endocrinol Invest; 2006 Mar; 29(3):244-7. PubMed ID: 16682838
    [Abstract] [Full Text] [Related]

  • 2. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F, Khoshniat M, Bahrainian M, Hedayati M.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [Abstract] [Full Text] [Related]

  • 3. Managing thyrotoxicosis in the acute medical setting.
    Napier C.
    Acute Med; 2018 Sep; 17(1):44-48. PubMed ID: 29589605
    [Abstract] [Full Text] [Related]

  • 4. Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants.
    Azizi F.
    J Pediatr; 1996 Jun; 128(6):855-8. PubMed ID: 8648549
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N, Yabu Y, Miyai K, Fujie T, Azukizawa M, Onishi T, Kumahara Y.
    Lancet; 1978 Aug 12; 2(8085):344-6. PubMed ID: 79711
    [Abstract] [Full Text] [Related]

  • 6. Thyroid dysfunction following pregnancy and implications for breastfeeding.
    Amino N, Arata N.
    Best Pract Res Clin Endocrinol Metab; 2020 Jul 12; 34(4):101438. PubMed ID: 32651061
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y, Takeoka K, Amino N.
    Endocr J; 2005 Aug 12; 52(4):493-7. PubMed ID: 16127219
    [Abstract] [Full Text] [Related]

  • 8. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
    Hidaka Y, Tamaki H, Iwatani Y, Tada H, Mitsuda N, Amino N.
    Clin Endocrinol (Oxf); 1994 Jul 12; 41(1):15-20. PubMed ID: 7914152
    [Abstract] [Full Text] [Related]

  • 9. Thyrotoxicosis.
    Franklyn J.
    Clin Med (Lond); 2003 Jul 12; 3(1):11-5. PubMed ID: 12617406
    [No Abstract] [Full Text] [Related]

  • 10. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB, Solomon BL, Cooper DS, Ferguson P, Walpert N, Howard R.
    J Clin Endocrinol Metab; 2001 Jul 12; 86(7):3016-21. PubMed ID: 11443161
    [Abstract] [Full Text] [Related]

  • 11. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
    Basaria S, Salvatori R.
    J Endocrinol Invest; 2002 Jul 12; 25(7):639-42. PubMed ID: 12150341
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and management of thyrotoxicosis.
    Pearce EN.
    BMJ; 2006 Jun 10; 332(7554):1369-73. PubMed ID: 16763249
    [No Abstract] [Full Text] [Related]

  • 13. Hyperthyroidism: A Review.
    Lee SY, Pearce EN.
    JAMA; 2023 Oct 17; 330(15):1472-1483. PubMed ID: 37847271
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis and management of thyrotoxicosis.
    Vaidya B, Pearce SH.
    BMJ; 2014 Aug 21; 349():g5128. PubMed ID: 25146390
    [No Abstract] [Full Text] [Related]

  • 15. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y, Hidaka Y, Tada H, Takano T, Kashiwai T, Tatsumi KI, Ichihara K, Amino N.
    Clin Endocrinol (Oxf); 2002 Jul 21; 57(1):51-8. PubMed ID: 12100069
    [Abstract] [Full Text] [Related]

  • 16. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC, Leung AAC.
    Recent Pat Endocr Metab Immune Drug Discov; 2017 Jul 21; 11(1):22-31. PubMed ID: 29589552
    [Abstract] [Full Text] [Related]

  • 17. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.
    Kubota S, Amino N, Matsumoto Y, Ikeda N, Morita S, Kudo T, Ohye H, Nishihara E, Ito M, Fukata S, Miyauchi A.
    Thyroid; 2008 Mar 21; 18(3):283-7. PubMed ID: 18001177
    [Abstract] [Full Text] [Related]

  • 18. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
    Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, Amino N.
    Endocr J; 2005 Oct 21; 52(5):537-42. PubMed ID: 16284430
    [Abstract] [Full Text] [Related]

  • 19. The treatment of post-partum thyroid disease.
    Owen PJ, Lazarus JH.
    J Endocrinol Invest; 2003 Apr 21; 26(4):290-1. PubMed ID: 12841533
    [No Abstract] [Full Text] [Related]

  • 20. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G, Sharma M, Devdhar M, Wexler JA, Carroll NM, Wartofsky L, Burman KD.
    Thyroid; 2010 Sep 21; 20(9):1015-8. PubMed ID: 20718680
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.